OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
Yanting Zhou, Hongyan Li
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Yanting Zhou, Hongyan Li
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Showing 7 citing articles:
Unusual presentation of a rare case of immunotherapy combination induced encephalitis: A case report
Pamela Sfeir, F. G. Kamar
Case Reports in Oncology (2025) Vol. 18, Iss. 1, pp. 206-212
Open Access
Pamela Sfeir, F. G. Kamar
Case Reports in Oncology (2025) Vol. 18, Iss. 1, pp. 206-212
Open Access
Pharmacological aspects of FDA-approved novel drug therapies against cancer in 2023: a comprehensive review
Kavita Sangwan, Parveen Kumar Goyal, Vipasha Sharma
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Kavita Sangwan, Parveen Kumar Goyal, Vipasha Sharma
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Immune Checkpoint Inhibitors: A Narrative Review on PD-1/PD-L1 Blockade Mechanism, Efficacy, and Safety Profile in Treating Malignancy
Nicolas D Benelli, Ian Brandon, Karina E. Hew
Cureus (2024)
Open Access | Times Cited: 4
Nicolas D Benelli, Ian Brandon, Karina E. Hew
Cureus (2024)
Open Access | Times Cited: 4
Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy
Zubaria Farzeen, Rana Rashad Mahmood Khan, Ayoub Rashid Chaudhry, et al.
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 8, pp. 1411-1431
Closed Access | Times Cited: 4
Zubaria Farzeen, Rana Rashad Mahmood Khan, Ayoub Rashid Chaudhry, et al.
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 8, pp. 1411-1431
Closed Access | Times Cited: 4
PD-1/PD-L1 Inhibitors for Alzheimer’s Pathology: A Literature Review
Samuel Huang, Yifei Long, Katie Lau, et al.
(2024)
Open Access
Samuel Huang, Yifei Long, Katie Lau, et al.
(2024)
Open Access
Clinical Patterns and Factors Contributing to Ophthalmic and Otologic Events Associated With Immune Checkpoint Inhibitors: A Narrative Review
Amal M Sunyur, Duaa Alkhayat, Heba A Mohammad, et al.
Cureus (2024)
Open Access
Amal M Sunyur, Duaa Alkhayat, Heba A Mohammad, et al.
Cureus (2024)
Open Access
Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors
Yuqian Wang, Lingeng Lu, Changquan Ling, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3984-3984
Open Access | Times Cited: 1
Yuqian Wang, Lingeng Lu, Changquan Ling, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3984-3984
Open Access | Times Cited: 1
